CereVasc, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CereVasc, Inc. - overview
Established
2014
Location
Boston, MA, US
Primary Industry
Medical Devices & Equipment
About
Based in Massachusetts, US, and founded in 2014 by co-founders Carl Heilman MD, Adel Malek Ph. D. , Daniel Levangie, and Patrick Sullivan, CereVasc, Inc. operates as a provider of the eShunt System for the treatment of communicating hydrocephalus in both children and adults with this condition.
In May 2024, CereVasc, Inc. raised USD 70 million in Series B funding co-led by Bain Capital and Perceptive Advisors. The company provides a wide range of neurological device solutions, such as the eShunt System to treat patients with communicating hydrocephalus.
Current Investors
Perceptive Advisors, ATON Partners, Bain Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Surgical Devices
Website
www.cerevasc.com/
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.